Clinical Trial Update: NeSST2: The Development of a Noninvasive Short Synacthen Test [Phase 2]

View source ↗

Summary

A Phase 2 study is developing a noninvasive short Synacthen test (NeSST2) to detect adrenal suppression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency

Snippet

Sponsor: Sheffield Children's NHS Foundation Trust | Conditions: Adrenal Suppression | Phase 2 | Status: RECRUITING